The expression status of five biomarker candidate factors and CD44 was examined by molecular pathological analysis using IHC to understand the biological characteristics of intravenous leiomyomatosis obtained from a patient with uterine leiomyoma (Supplementary Material 2). This evidence concerns the gene CD44 and Uterine leiomyoma.